ArticleViruses2020

ART-Treated Patients Exhibit an Adaptive Immune Response against the HFVAC Peptides, a Potential HIV-1 Therapeutic Vaccine (Provir/Latitude45 Study).

Hervé Fleury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.